A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of MEDI9929 After Single Administration in Healthy Male Japanese Subjects
Clinical trial NCT01913028 · COMPLETED
Trial details
- NCT number
- NCT01913028
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2014-01-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.